Clinical Trials & Project Pipeline

Biocytics™ is committed to advancing the treatment of cancer.  We are currently conducting an Institutional Review Board-approved clinical trial as part of our BioEngineering efforts to improve cancer therapy.  Called Biocytics™ 0001, this trial is part of our initial efforts towards personalized cancer medicine.  More detailed information can be found about Biocytics™ 0001 by clicking on the Clinical Trials tab on the left. 

Biocytics™ has additional projects underway in the BioEngineering division, as well as the BioBank and the BioMedical Informatics divisions.  Click on the Project Pipeline tab for a diagram of our projects and their development.